Birchcreek Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Birchcreek Wealth Management's ABBV Position: Q2 2026 in Review
Birchcreek Wealth Management increased its AbbVie (ABBV) stake by 40% in Q2 2026, buying an estimated $147K and bringing the position to 2,402 shares worth $604K. The position accounts for 0.24% of the portfolio, ranked #67.
Birchcreek Wealth Management first reported a position in ABBV in Q4 2020 and has held it in 19 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Birchcreek Wealth Management held 2,402 shares of AbbVie worth $604K as of Q2 2026.
- Birchcreek Wealth Management bought 683 AbbVie shares in Q2 2026, an estimated $147K.
- AbbVie made up 0.24% of Birchcreek Wealth Management's portfolio in Q2 2026, its #67 holding.
- Birchcreek Wealth Management first reported a position in AbbVie in Q4 2020 and has held it in 19 quarters since.
- 4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Birchcreek Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.